{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:36:37Z","timestamp":1791178597161,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":34,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004156.pub3","type":"reference-entry","created":{"date-parts":[[2006,1,20]],"date-time":"2006-01-20T04:08:27Z","timestamp":1137730107000},"source":"Crossref","is-referenced-by-count":10,"title":["Treatment for spasticity in amyotrophic lateral sclerosis\/motor neuron disease"],"prefix":"10.1002","author":[{"given":"Nigel L","family":"Ashworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L E","family":"Satkunam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Deforge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"issue":"1-2","key":"10.1002\/14651858.CD004156.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-510X(01)00610-4","article-title":"The value of muscle exercise in patients with amyotrophic lateral sclerosis","volume":"191","author":"Drory","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"issue":"9","key":"10.1002\/14651858.CD004156.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis","volume":"330","author":"Bensimon","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD004156.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF02339903","article-title":"Protirilen tartrate (TRH-T) in upper motoneuron syndrome: a controlled neurophysiological and clinical study","volume":"15","author":"Civardi","year":"1994","journal-title":"Italian Journal of Neurological Sciences"},{"issue":"10","key":"10.1002\/14651858.CD004156.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/jnnp.50.10.1359","article-title":"Controlled acute trial of a thyrotrophin releasing hormone analogue (RX77368) in motor neuron disease","volume":"50","author":"Guiloff","year":"1987","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD004156.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archneur.1979.00500470085019","article-title":"Trial of Baclofen in amyotrophic lateral sclerosis","volume":"36","author":"Norris FH Jr","year":"1979","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD004156.pub3-BIB6|cit6","first-page":"192","article-title":"Preliminary trial of Carisprodol in multiple sclerosis","author":"Ashworth","year":"1964","journal-title":"Practitioner"},{"issue":"1","key":"10.1002\/14651858.CD004156.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0141-5425(84)90003-7","article-title":"Pendulum testing of spasticity","volume":"6","author":"Bajd","year":"1984","journal-title":"Journal of Biomedical Engineering"},{"issue":"8","key":"10.1002\/14651858.CD004156.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00005650-198108000-00001","article-title":"The Sickness Impact Profile: development and final revision of a health status measure","volume":"19","author":"Bergner","year":"1981","journal-title":"Medical Care"},{"issue":"2","key":"10.1002\/14651858.CD004156.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","article-title":"Interrater reliability of a modified Ashworth scale of muscle spasticity","volume":"67","author":"Bohannon","year":"1987","journal-title":"Physical Therapy"},{"issue":"Suppl","key":"10.1002\/14651858.CD004156.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","article-title":"El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases\/Amyotrophic Lateral Sclerosis of the World Federation of Research Group on Neuromuscular Diseases and the El Escorial \"Clinical Limits of amyotrophic lateral sclerosis\" workshop contributors","volume":"124","author":"Brooks","year":"1994","journal-title":"Journal of the Neurological Sciences"},{"issue":"5","key":"10.1002\/14651858.CD004156.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders"},{"issue":"1","key":"10.1002\/14651858.CD004156.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1047-9651(18)30290-0","article-title":"Comprehensive management of amyotrophic lateral sclerosis","volume":"9","author":"Carter","year":"1998","journal-title":"Physical Medicine and Rehabilitation Clinics of North America"},{"issue":"12","key":"10.1002\/14651858.CD004156.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/jnnp.55.12.1106","article-title":"Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950","volume":"55","author":"Chancellor","year":"1992","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD004156.pub3-BIB14|cit14","volume-title":"The handbook of research synthesis","author":"Cooper","year":"1994"},{"issue":"1","key":"10.1002\/14651858.CD004156.pub3-BIB15|cit15","first-page":"47","article-title":"Gabapentin for the treatment of spasticity in patients with ALS","volume":"2","author":"Carvalho","year":"2001","journal-title":"Amyotrophic lateral sclerosis & other motor neuron disorders"},{"issue":"2","key":"10.1002\/14651858.CD004156.pub3-BIB16|cit16","first-page":"67","article-title":"Featured instrument. The Functional Independence Measure (FIM instrument)","volume":"1","author":"Deutsch","year":"1997","journal-title":"Journal of Rehabilitation Outcomes Measurement"},{"key":"10.1002\/14651858.CD004156.pub3-BIB17|cit17","first-page":"1","article-title":"The motor neuron diseases and related disorders","volume-title":"Clinical Neurology","volume":"4","author":"Hudson","year":"1991"},{"issue":"1","key":"10.1002\/14651858.CD004156.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD004156.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0003-9993(92)90007-J","article-title":"Objective quantification of spastic hypertonia: correlation with clinical findings","volume":"73","author":"Katz","year":"1992","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"5","key":"10.1002\/14651858.CD004156.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0003-9993(21)01620-8","article-title":"The effect of a high resistance exercise program in slowly progressive neuromuscular disease","volume":"75","author":"Kilmer","year":"1994","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"7","key":"10.1002\/14651858.CD004156.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s004150050417","article-title":"Intrathecal baclofen for intractable spasticity in ALS","volume":"256","author":"Marquardt","year":"1999","journal-title":"Journal of Neurology"},{"issue":"Suppl","key":"10.1002\/14651858.CD004156.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/(SICI)1097-4598(1997)6+<1::AID-MUS2>3.0.CO;2-D","article-title":"Clinicophysiological concepts of spasticity and motor dysfunction in adults with an upper motorneuron lesion","volume":"6","author":"Mayer","year":"1997","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.1002\/14651858.CD004156.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00002060-199905000-00012","article-title":"Continuously infused intrathecal baclofen for spastic\/dystonic hemiplegia","volume":"78","author":"Meythaler","year":"1999","journal-title":"American Journal of Physical Medicine and Rehabilitation"},{"issue":"5","key":"10.1002\/14651858.CD004156.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0404.1992.tb04048.x","article-title":"Mechanisms of baclofen action on spasticity","volume":"85","author":"Milanov","year":"1992","journal-title":"Acta Neurologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD004156.pub3-BIB25|cit25","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001447","article-title":"Riluzole for Amyotrophic Lateral Sclerosis (ALS) \/ Motor Neurone Disease (MND) (Cochrane Review)","author":"Miller","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004156.pub3-BIB26|cit26","first-page":"p41","volume-title":"The diagnosis and treatment of Amyotrophic Lateral Sclerosis","author":"Mulder DW","year":"1980"},{"issue":"4","key":"10.1002\/14651858.CD004156.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1212\/WNL.36.4.511","article-title":"Familial adult motor neuron disease: Amyotrophic Lateral Sclerosis","volume":"36","author":"Mulder","year":"1986","journal-title":"Neurology"},{"issue":"11Suppl 9","key":"10.1002\/14651858.CD004156.pub3-BIB28|cit28","first-page":"S44","article-title":"Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group","volume":"44","author":"Nance","year":"1994","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004156.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0022-510X(93)90245-T","article-title":"Onset, natural history and outcome in idiopathic adult motor neuron disease","volume":"118","author":"Norris","year":"1993","journal-title":"Journal of the Neurological Sciences"},{"issue":"23","key":"10.1002\/14651858.CD004156.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM198906083202303","article-title":"Intrathecal baclofen for severe spinal spasticity","volume":"320","author":"Penn","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"3-4","key":"10.1002\/14651858.CD004156.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0361-9230(93)90269-H","article-title":"Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartate-glutamate in amyotrophic lateral sclerosis","volume":"30","author":"Plaitaikis","year":"1993","journal-title":"Brain Research Bulletin"},{"issue":"5","key":"10.1002\/14651858.CD004156.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD004156.pub3-BIB33|cit33","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001332","article-title":"Anti-spasticity agents for multiple sclerosis (Cochrane review)","author":"Shakespeare","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004156.pub3-BIB34|cit34","first-page":"237","article-title":"Baclofen effect on quadriceps strength in multiple sclerosis","volume":"73","author":"Smith","year":"1992","journal-title":"Archives of Physical Medicine & Rehabilitation"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004156.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T00:00:00Z","timestamp":1329264000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004156.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T07:04:52Z","timestamp":1683356692000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004156.pub3"}},"subtitle":[],"editor":[{"given":"Nigel L","family":"Ashworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2006,1,25]]},"references-count":34,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004156.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004156.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2006,1,25]]}}}